Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
Excessive glutamate release has been linked to stress and many neurodegenerative diseases. Evidence indicates abnormalities of glutamatergic neurotransmission or glutamatergic dysfunction as playing an important role in the development of many major psychiatric disorders (e.g., schizophrenia, bipola...
Main Authors: | Cheng-Ta Li, Kai-Chun Yang, Wei-Chen Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2018.00767/full |
Similar Items
-
Glutamatergic System and Schizophrenia
by: Osman Ozdemir, et al.
Published: (2016-12-01) -
Neuroimaging with Radiopharmaceuticals Targeting the Glutamatergic System
by: Linjing Mu, et al.
Published: (2020-12-01) -
Overview of Glutamatergic Dysregulation in Central Pathologies
by: Tanya Miladinovic, et al.
Published: (2015-11-01) -
Assessment of glutamatergic synaptic transmission and plasticity in brain slices: relevance to bioelectronic approaches
by: Eric H. Chang, et al.
Published: (2019-06-01) -
Somatostatin, a Presynaptic Modulator of Glutamatergic Signal in the Central Nervous System
by: Anna Pittaluga, et al.
Published: (2021-05-01)